000 02414 a2200661 4500
005 20250517061651.0
264 0 _c20160920
008 201609s 0 0 eng d
022 _a2352-3018
024 7 _a10.1016/S2352-3018(15)00181-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBernardino, Jose I
245 0 0 _aBone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
_h[electronic resource]
260 _bThe lancet. HIV
_cNov 2015
300 _ae464-73 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAbsorptiometry, Photon
650 0 4 _aAdult
650 0 4 _aAnti-HIV Agents
_xadministration & dosage
650 0 4 _aBiomarkers
_xblood
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Diseases, Metabolic
_xchemically induced
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aComorbidity
650 0 4 _aDarunavir
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEmtricitabine
_xadministration & dosage
650 0 4 _aEurope
_xepidemiology
650 0 4 _aFemale
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHumans
650 0 4 _aInflammation
_xphysiopathology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOsteopetrosis
_xchemically induced
650 0 4 _aRaltegravir Potassium
_xadministration & dosage
650 0 4 _aRitonavir
_xadministration & dosage
650 0 4 _aTenofovir
_xadministration & dosage
650 0 4 _aViral Load
700 1 _aMocroft, Amanda
700 1 _aMallon, Patrick W
700 1 _aWallet, Cedrick
700 1 _aGerstoft, Jan
700 1 _aRussell, Charlotte
700 1 _aReiss, Peter
700 1 _aKatlama, Christine
700 1 _aDe Wit, Stephane
700 1 _aRichert, Laura
700 1 _aBabiker, Abdel
700 1 _aBuño, Antonio
700 1 _aCastagna, Antonella
700 1 _aGirard, Pierre-Marie
700 1 _aChene, Genevieve
700 1 _aRaffi, Francois
700 1 _aArribas, Jose R
773 0 _tThe lancet. HIV
_gvol. 2
_gno. 11
_gp. e464-73
856 4 0 _uhttps://doi.org/10.1016/S2352-3018(15)00181-2
_zAvailable from publisher's website
999 _c25406170
_d25406170